Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$164.35−5.61 (-3.30%)
Close on Nov 13, 2026Market cap $6.47BP/E –Yield –
Belite Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Belite Bio's price to book ratio was 8.0× on Nov 11, 2026, against 30.0× a year earlier. Over the last 4 years it ranged from 7.4× to 36.9×, with a median of 14.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.0× | −26.9 |
| 2025 | Dec 31, 2025 | 34.9× | +14.6 |
| 2024 | Dec 31, 2024 | 20.3× | −7.1 |
| 2023 | Dec 29, 2023 | 27.4× | – |
See a number that looks wrong?